BH4-domain peptide from Bcl-xL exerts anti-apoptotic activity in vivo

Oncogene

Volumn 22, Issue 52, 2003, Pages 8432-8440

  Sugioka, Rie ^a,b   Shimizu, Shigeomi ^a,b   Funatsu, Toshihiro ^a   Tamagawa, Hiroshi ^a   Sawa, Yoshiki ^a   Kawakami, Toru ^c   Tsujimoto, Yoshihide ^a,b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Bcl xL; BH4 domain; Mitochondria; TAT

Indexed keywords

CYTOCHROME C; ETOPOSIDE; FAS ANTIGEN; HYBRID PROTEIN; PEPTIDE DERIVATIVE; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BH4; TAT BH4 PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEPATITIS; HUMAN; HUMAN CELL; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; REPERFUSION INJURY; SMALL INTESTINE; X RAY;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; HELA CELLS; HEPATITIS; HUMANS; INTESTINE, SMALL; MICE; MYOCARDIAL REPERFUSION INJURY; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-BCL-2; X-RAYS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; RODENTIA;

EID: 0346753589     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207180     Document Type: Article

References (41)

1. Adams JM and Cory S. (1998). Science, 281, 1322-1326.
2. Borner C, Martinou I, Mattmann C, Irmler M, Schaerer E, Martinou JC and Tschopp J. (1994). J. Cell Biol., 126, 1059-1068.
3. Du C, Fang M, Li Y, Li L and Wang X. (2000). Cell, 102, 33-42.
4. Eskes R, Desagher S, Antonsson B and Martinou JC. (2000). Mol. Cell. Biol., 20, 929-935.
5. Green DR and Reed JC. (1998). Science, 281, 1309-1312.
6. Hanada M, Aime-Sempe C, Sato T and Reed JC. (1995). J. Biol. Chem., 270, 11962-11969.
7. Hirotani M, Zhang Y, Fujita N, Naito M and Tsuruo T. (1999). J. Biol. Chem., 274, 20415-20420.
8. Hockenbery DM. (1992). Semin. Immunol., 4, 413-420.
9. Huang DC, Adams JM and Cory S. (1998). EMBO J., 17, 1029-1039.
10. Hunter JJ, Bond BL and Parslow TG. (1996). Mol. Cell. Biol., 16, 877-883.
11. Kuwana T, Mackey MR, Perkins G, Ellisman MH, Latterich M, Schneiter R, Green DR and Newmeyer DD. (2002). Cell, 111, 331-342.
12. Lee LC, Hunter JJ, Mujeeb A, Turck C and Parslow TG. (1996). J. Biol. Chem., 271, 23284-23288.
13. Macho A, Calzado MA, Jimenez-Reina L, Ceballos E, Leon J and Munoz E. (1999). Oncogene, 18, 7543-7551.
14. Martinou JC and Green DR. (2001). Nat. Rev. Mol. Cell Biol., 2, 63-67.
15. Niwa H, Yamamura K and Miyazaki J. (1991). Gene, 108, 193-199.
16. Oltvai ZN, Milliman CL and Korsmeyer SJ. (1993). Cell, 74, 609-619.
17. Park IW, Ullrich CK, Schoenberger E, Ganju RK and Groopman JE. (2001). J. Immunol., 167, 2766-2771.
18. Saikumar P, Dong Z, Weinberg JM and Venkatachalam MA. (1998). Oncogene, 17, 3341-3349.
19. Saito M, Korsmeyer SJ and Schlesinaer PH. (2000). Nat. Cell Biol., 2, 553-555.
20. Schwarze SR, Hruska KA and Dowdy SF. (2000). Trends Cell Biol., 10, 290-295.
21. Schwarze SR, Ho A, Vocero-Akbani A and Dowdy SF. (1999). Science, 285, 1569-1572.
22. Shibasaki F, Kondo E, Akagi T and McKeon F. (1997). Nature, 386, 728-731.
23. Shimizu S, Kamiike W, Hatanaka N, Nishimura M, Miyata M, Inoue T, Yoshida Y, Tagawa K and Matsuda H. (1994). Transplantation, 57, 144-148.
24. Shimizu S, Eguchi Y, Kamiike W, Itoh Y, Hasegawa J, Yamabe K, Otsuki Y, Matsuda H and Tsujimoto Y. (1996a). Cancer Res., 56, 2161-2166.
25. Shimizu S, Eguchi Y, Kamiike W, Matsuda H and Tsujimoto Y. (1996b). Oncogene, 12, 2251-2257.
26. Shimizu S, Narita M and Tsujimoto Y. (1999). Nature, 399, 483-487.
27. Shimizu S, Ide T, Yanagida T and Tsujimoto Y. (2000a). J. Biol. Chem., 275, 12321-12325.
28. Shimizu S, Konishi A, Kodama T and Tsujimoto Y. (2000b). Proc. Natl. Acad. Sci. USA, 97, 3100-3105.
29. Shimizu S, Matsuoka Y, Shinohara Y, Yoneda Y and Tsujimoto Y. (2001). J. Cell Biol., 152, 237-250.
30. Solem LE and Wallace KB. (1993). Toxicol. Appl. Pharmacol., 121, 50-57.
31. Suzuki K, Sawa Y, Kaneda Y, Ichikawa H, Shirakura R and Matsuda H. (1997). J. Clin. Invest., 99, 1645-1650.
32. Tsujimoto Y and Shimizu S. (2000a). FEBS Lett., 466, 6-10.
33. Tsujimoto Y and Shimizu S. (2000b). Cell Death Differ., 7, 1174-1181.
34. Tsujimoto Y. (2003). J. Cell. Physiol., 195, 158-167.
35. Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, Moritz RL, Simpson RJ and Vaux DL. (2000). Cell, 102, 43-53.
36. Wang HG, Rapp UR and Reed JC. (1996). Cell, 87, 629-638.
37. Wang X. (2001). Genes Dev., 15, 2922-2933.
38. Wei MC, Lindsten T, Mootha VK, Weiler S, Gross A, Ashiya M, Thompson CB and Korsmeyer SJ. (2000). Genes Dev., 14, 2060-2071.
39. Yamabe K, Shimizu S, Kamiike W, Waguri S, Eguchi Y, Hasegawa J, Okuno S, Yoshioka Y, Ito T, Sawa Y, Uchiyama Y, Tsujimoto Y and Matsuda H. (1998). Biochem. Biophys. Res. Commun., 243, 217-223.
40. Yang E, Zha J, Jockel J, Boise LH, Thompson CB and Korsmeyer SJ. (1995). Cell, 80, 285-291.
41. Zamzami N and Kroemer G. (2001). Nat. Rev. Mol. Cell Biol., 2, 67-71.